Dysregulation of TFH-B-TRM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer
Jae-Won Cho(Yonsei University), Hye Ryun Kim(Yonsei University), Yong‐Soo Bae(Sungkyunkwan University), Insuk Lee(Pohang University of Science and Technology), Sang‐Jun Ha(Yonsei University), Heonjong Han(Unknown), Seyeon Park(Dongduk Women's University), Sung Yong Park(Ajou University), Sunhye Shin(Yonsei University), Gamin Kim(Yonsei University), Hyo Sup Shim(Yonsei University)
Cited by 64
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
|Nucleic Acids Research|2017|2.1k
TRRUST: a reference database of human transcriptional regulatory interactions
|Scientific Reports|2015|492
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
|Experimental & Molecular Medicine|2020|282
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
|Annals of Oncology|2013|125